Related Experiment Video
Updated: Jul 1, 2026
03:40
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Caffeine Consumption and Rhinologic Symptom Severity
Duncan G J Green1, Steven X Wang2, Michael S DeBakey2
1Department of Otorhinolaryngology, Ochsner Health, New Orleans, Los Angeles, USA.
Summary
Caffeine consumption does not appear to affect rhinologic symptoms. This study found no correlation between daily caffeine intake and the severity of nasal symptoms in 226 participants.
Area of Science:
- Otolaryngology
- Clinical Pharmacology
Background:
- Caffeine is a widely consumed psychoactive substance.
- A potential link between caffeine intake and rhinologic symptoms has been suggested.
- The impact of caffeine withdrawal versus potential symptom relief requires investigation.
Purpose of the Study:
- To investigate the association between caffeine consumption and rhinologic symptom severity.
- To determine if caffeine withdrawal effects outweigh potential benefits for nasal symptoms.
Main Methods:
- Prospective study design involving 226 participants with rhinologic complaints.
- Assessment of rhinologic symptom severity using the Sino-Nasal Outcome Test 22 (SNOT-22).
- Quantification of daily caffeine consumption via questionnaires.
Main Results:
- No statistically significant correlation was found between caffeine consumption and total SNOT-22 scores (P > .05).
- No significant association observed with the rhinologic subscale of the SNOT-22 (P > .05).
- No difference in symptom severity across low, medium, and high caffeine consumption tertiles (P = .18).
Conclusions:
- Caffeine consumption does not demonstrate an appreciable effect on overall rhinologic symptom severity.
- Findings suggest that caffeine intake is unlikely to influence the experience of nasal symptoms.
Related Concept Videos
01:16Drugs Used in Upper Respiratory Disorders: Overview
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
01:27Upper Respiratory Drugs: Decongestants
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in various...
Most decongestants are readily available over-the-counter in various...
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
01:28Adrenergic Agonists: Mixed-Action Agents
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:24Asthma-III: Symptoms and Complications
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma